loadpatents
Patent applications and USPTO patent grants for Kahn; C. Ronald.The latest application filed is for "targeting mirnas for exosomal delivery or cellular retention".
Patent | Date |
---|---|
Targeting Mirnas for Exosomal Delivery or Cellular Retention App 20210171949 - Kahn; C. Ronald ;   et al. | 2021-06-10 |
Exosome Delivery System App 20190338314 - Kahn; C. Ronald ;   et al. | 2019-11-07 |
High-throughput Image-based Chemical Screening In Zebrafish Blastomere Cell Culture App 20180112182 - ZON; Leonard I. ;   et al. | 2018-04-26 |
High-throughput image-based chemical screening in zebrafish blastomere cell culture Grant 9,771,560 - Zon , et al. September 26, 2 | 2017-09-26 |
Methods And Compositions For Induction Of Ucp1 Expression App 20170173114 - Kahn; C. Ronald ;   et al. | 2017-06-22 |
Glypican-4 based compositions and methods for treating and diagnosing insulin resistance Grant 9,446,096 - Ussar , et al. September 20, 2 | 2016-09-20 |
Methods and compositions for inducing brown adipogenesis Grant 9,346,869 - Tseng , et al. May 24, 2 | 2016-05-24 |
Methods and compositions for modulating adipocyte function Grant 9,132,169 - Kahn , et al. September 15, 2 | 2015-09-15 |
High-throughput Image-based Chemical Screening In Zebrafish Blastomere Cell Culture App 20150147807 - Zon; Leonard I. ;   et al. | 2015-05-28 |
Novel Surface Markers For Adipose Tissue App 20150147292 - Kahn; C. Ronald ;   et al. | 2015-05-28 |
Glypican-4 Based Compositions And Methods For Treating And Diagnosing Insulin Resistance App 20140364363 - Ussar; Siegfried ;   et al. | 2014-12-11 |
Methods And Compositions For Inducing Brown Adipogenesis App 20140296325 - Tseng; Yu-Hua ;   et al. | 2014-10-02 |
Compositions And Methods For The Treatment Of Nervous Disorders Associated With Diabetes App 20140194353 - Kahn; C. Ronald ;   et al. | 2014-07-10 |
Bone Morphogenetic Proteins For The Treatment Of Insulin Resistance App 20140107026 - Tseng; Yu-Hua ;   et al. | 2014-04-17 |
Methods And Compositions For Modulating Adipocyte Function App 20120251457 - Kahn; C. Ronald ;   et al. | 2012-10-04 |
Use Of Protein Kinase C Delta (pkcd) Inhibitors To Treat Diabetes, Obesity, And Hepatic Steatosis App 20120208750 - Kahn; C. Ronald ;   et al. | 2012-08-16 |
Bone Morphogenetic Proteins For The Treatment Of Insulin Resistance App 20120135927 - Tseng; Yu-Hua ;   et al. | 2012-05-31 |
Methods and compositions for modulating adipocyte function Grant 8,178,492 - Kahn , et al. May 15, 2 | 2012-05-15 |
Methods and Compositions for Modulating Adipocyte Function App 20110117049 - Kahn; C. Ronald ;   et al. | 2011-05-19 |
Methods and compositions for modulating Necdin function Grant 7,825,098 - Kahn , et al. November 2, 2 | 2010-11-02 |
Methods And Compositions For Inducing Brown Adipogenesis App 20100150885 - Tseng; Yu-Hua ;   et al. | 2010-06-17 |
Methods of treating diabetes Grant 7,700,555 - Gunton , et al. April 20, 2 | 2010-04-20 |
Obesity And Body Fat Distribution App 20090220973 - Gesta; Stephane ;   et al. | 2009-09-03 |
Methods and compositions for modulating adipocyte function Grant 7,576,052 - Kahn , et al. August 18, 2 | 2009-08-18 |
Methods of diagnosis and treatment of metabolic disorders App 20090142335 - Kahn; C. Ronald ;   et al. | 2009-06-04 |
Methods of Treating Diabetes Using Inhibitors of ARNT2 App 20080102032 - Gunton; Jenny ;   et al. | 2008-05-01 |
Methods of treating diabetes App 20070253904 - Gunton; Jenny ;   et al. | 2007-11-01 |
Methods and compositions for modulating necdin function App 20060223104 - Kahn; C. Ronald ;   et al. | 2006-10-05 |
Methods and compositions for modulating adipocyte function App 20050187154 - Kahn, C. Ronald ;   et al. | 2005-08-25 |
Modulators of p85 expression App 20040028683 - Kahn, C. Ronald ;   et al. | 2004-02-12 |
Modulating the Rad-nm23 interaction App 20030013673 - Kahn, C. Ronald ;   et al. | 2003-01-16 |
Modulators of p85 expression App 20020051786 - Kahn, C. Ronald ;   et al. | 2002-05-02 |
Insulin receptor substrate Grant 5,621,075 - Kahn , et al. April 15, 1 | 1997-04-15 |
Isolated DNA encoding an insulin receptor substrate Grant 5,260,200 - Kahn , et al. November 9, 1 | 1993-11-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.